We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Etude Tomos- Apport de la Tomosynthèse Dans le Bilan d'Extension locorégional préthérapeutique d'Une Tumeur du Sein : Recherche de multicentricité Tomos Study- Contribution of Tomosynthesis In Locoregional Pretherapeutic Staging of a Breast Tumor: Multicentricity Search

This study has been terminated.
(No more inclusions since august 2013)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01522300
First Posted: January 31, 2012
Last Update Posted: November 21, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Centre Jean Perrin
  Purpose
The main objective of the study is to assess the sensitivity and specificity of Tomosynthesis in detecting the multicentricity of mammary tumor.

Condition Intervention Phase
Mammary Tumor Other: Evaluation of the Tomosynthesis Other: Avaluation of a medical device: the tomosynthesis Phase 2

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Diagnostic
Official Title: Etude Tomos- Apport de la Tomosynthèse Dans le Bilan d'Extension locorégional préthérapeutique d'Une Tumeur du Sein : Recherche de multicentricité

Resource links provided by NLM:


Further study details as provided by Centre Jean Perrin:

Primary Outcome Measures:
  • To calculate the sensitivity and specificity of both types of imaging (mammography and Tomosynthesis) with respect to number of tumors multicentric and multifocal identified through MRI. [ Time Frame: January 2013 ]
    To calculate the sensitivity and specificity of both types of imaging (mammography and Tomosynthesis) with respect to number of tumors multicentric and multifocal identified through MRI. The other parameters VPN, VPP will also be calculated and discussed.


Enrollment: 81
Study Start Date: January 2012
Study Completion Date: August 2013
Primary Completion Date: August 2013 (Final data collection date for primary outcome measure)
Intervention Details:
    Other: Evaluation of the Tomosynthesis
    An exam by tomosynthesis will be realised at the inclusion of the patient in the study.
    Other: Avaluation of a medical device: the tomosynthesis
    An exam by tomosynthesis will be realised at the inclusion of the patient in the study
Detailed Description:

The secondaries objectives of the study are:

  • Sensitivity and specificity in detecting multifocality of breast tumor
  • Sensitivity and specificity of Tomosynthesis in the detection of contralateral tumors
  • Predetermination of potential targets for ultrasound
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Age> 18 years.
  • Patients with a breast tumor, regardless of the stage and size
  • Compulsory affiliation to a social security system.
  • Obtaining informed consent in writing, signed and dated.

Exclusion Criteria:

  • Patients with cognitive or psychiatric disorders.
  • Patient deprived of liberty by a court or administrative.
  • Patients with indications against the achievement of MRI, mammography and tomosynthesis
  • Pregnant Women
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01522300


Locations
France
Centre Jean Perrin
Clermont Ferrand, France, 63011
Sponsors and Collaborators
Centre Jean Perrin
  More Information

Responsible Party: Centre Jean Perrin
ClinicalTrials.gov Identifier: NCT01522300     History of Changes
Other Study ID Numbers: TOMOS
First Submitted: January 18, 2012
First Posted: January 31, 2012
Last Update Posted: November 21, 2013
Last Verified: November 2013

Keywords provided by Centre Jean Perrin:
Tomosynthesis
breast cancer
specificity
sensitivity
To assess efficacy of Tomosynthesis by evaluating its sensitivity and specificity in detecting the multicentricity of mammary tumor

Additional relevant MeSH terms:
Breast Neoplasms
Neoplasms by Site
Neoplasms
Breast Diseases
Skin Diseases